+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America and Europe Sepsis Diagnostics Market Size, Share & Trends Analysis Report by Product, Technology, Pathogen, Testing, Method, End Use, Country with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • February 2025
  • Region: Europe, North America
  • Grand View Research
  • ID: 6056010
Description Jump to:
The North America and Europe Sepsis Diagnostics Market was valued at USD 816.1 million in 2024, and is projected to reach USD 1.24 billion by 2030, rising at a CAGR of 7.30%. North America experiences a significant prevalence of sepsis, making it a leading cause of hospital deaths. This high incidence drives the demand for effective diagnostic solutions. Favorable reimbursement policies also encourage healthcare providers to adopt advanced diagnostics, while increased awareness and public-private funding boost the development of innovative tools.

In Europe, stringent regulations ensure reliable sepsis testing methods are available, supporting market growth. The aging population, more susceptible to infections, further escalates the demand for tailored diagnostic solutions. In addition, the rising healthcare spending enhances access to advanced diagnostics across European countries.

The European Centre for Disease Prevention and Control (ECDC) reported in 2024 that HAIs affected around 4.5 million patients annually, with sepsis as a major consequence. In 2023, the UK government allocated approximately USD 12 million for antimicrobial resistance (AMR) research, directly aiding sepsis management initiatives. Moreover, projected federal funding for sepsis-related programs in the U.S. was expected to exceed USD 50 million in 2024, aimed at improving diagnostic technologies and reducing mortality rates associated with sepsis.

North America And Europe Sepsis Diagnostics Market Report Highlights

  • Based on product, blood culture media held over 30.0% market share in 2023, while assay kits and reagents are poised for lucrative growth from 2025 to 2030 onwards
  • Microbiology led the technology segment in 2024, while molecular diagnostics are anticipated to witness the fastest rate of 9.3% over the forecast period
  • Based on pathogen, bacterial sepsis held the largest market share in 2024, driven by significant mortality rates, rising HAIs, and technological advancements. It is also expected to grow at the fastest CAGR over the forecast period
  • Based on testing, POC testing is expected to grow at a staggering 9.6% CAGR as laboratory testing led the testing segment
  • Based on method, automated diagnostic methods are expected to grow at the fastest CAGR over the forecast period
  • The U.S. dominated the North America sepsis diagnostics market as the shift to value-based care promotes early detection, while supportive reimbursement, increased awareness, and government initiatives enhance sepsis management innovations.
  • The UK sepsis diagnostics market is expected to grow at the fastest rate of 8.1% over the forecast period in the Europe market
  • In March 2024, BD collaborated with GOCC in Poland to enhance access to advanced bloodstream infection testing, deploying state-of-the-art microbiology equipment across over 150 hospitals and clinics for improved sepsis management

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Pathogen
1.2.4. Testing
1.2.5. Method
1.2.6. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. North America and Europe Sepsis Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. North America and Europe Sepsis Diagnostics Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments Market, 2018-2030 (USD Million)
4.5. Blood Culture Media
4.5.1. Blood Culture Media Market, 2018-2030 (USD Million)
4.6. Assay Kits and Reagents
4.6.1. Assay Kits and Reagents Market, 2018-2030 (USD Million)
4.7. Software
4.7.1. Software Market, 2018-2030 (USD Million)
Chapter 5. North America and Europe Sepsis Diagnostics Market: Technology Business Analysis
5.1. Technology Market Share, 2024 & 2030
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Microbiology
5.4.1. Microbiology Market, 2018-2030 (USD Million)
5.5. Molecular Diagnostics
5.5.1. Molecular Diagnostics Market, 2018-2030 (USD Million)
5.5.2. Polymerase Chain Reaction (PCR)
5.5.2.1. Polymerase Chain Reaction (PCR) Market, 2018-2030 (USD Million)
5.5.3. DNA Microarrays
5.5.3.1. DNA Microarrays Market, 2018-2030 (USD Million)
5.5.4. Syndromic Panel Testing
5.5.4.1. Syndromic Panel Testing Market, 2018-2030 (USD Million)
5.5.5. Others
5.5.5.1. Others Market, 2018-2030 (USD Million)
5.6. Immunoassays
5.6.1. Immunoassays Market, 2018-2030 (USD Million)
5.7. Flow Cytometry
5.7.1. Flow Cytometry Market, 2018-2030 (USD Million)
5.8. Others
5.8.1. Others Market, 2018-2030 (USD Million)
Chapter 6. North America and Europe Sepsis Diagnostics Market: Pathogen Business Analysis
6.1. Pathogen Market Share, 2024 & 2030
6.2. Pathogen Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Pathogen, 2018 to 2030 (USD Million)
6.4. Bacterial Sepsis
6.4.1. Bacterial Sepsis Market, 2018-2030 (USD Million)
6.4.2. Gram-positive Bacteria
6.4.2.1. Gram-positive Bacteria Market, 2018-2030 (USD Million)
6.4.3. Gram-negative Bacteria
6.4.3.1. Gram-negative Bacteria Market, 2018-2030 (USD Million)
6.5. Fungal Sepsis
6.5.1. Fungal Sepsis Market, 2018-2030 (USD Million)
6.6. Viral Sepsis
6.6.1. Viral Sepsis Market, 2018-2030 (USD Million)
6.7. Others
6.7.1. Others Market, 2018-2030 (USD Million)
Chapter 7. North America and Europe Sepsis Diagnostics Market: Testing Business Analysis
7.1. Testing Market Share, 2024 & 2030
7.2. Testing Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Testing, 2018 to 2030 (USD Million)
7.4. Laboratory Testing
7.4.1. Laboratory Testing Market, 2018-2030 (USD Million)
7.5. PoC Testing
7.5.1. PoC Testing Market, 2018-2030 (USD Million)
Chapter 8. North America and Europe Sepsis Diagnostics Market: Method Business Analysis
8.1. Method Market Share, 2024 & 2030
8.2. Method Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by Method, 2018 to 2030 (USD Million)
8.4. Automated Diagnostics
8.4.1. Automated Diagnostics Market, 2018-2030 (USD Million)
8.5. Conventional Diagnostics
8.5.1. Conventional Diagnostics Market, 2018-2030 (USD Million)
Chapter 9. North America and Europe Sepsis Diagnostics Market: End Use Business Analysis
9.1. End Use Market Share, 2024 & 2030
9.2. End Use Segment Dashboard
9.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
9.4. Hospitals & Clinics
9.4.1. Hospitals & Clinics Market, 2018-2030 (USD Million)
9.5. Pathology & Reference Laboratories
9.5.1. Pathology & Reference Laboratories Market, 2018-2030 (USD Million)
9.6. Research Institutes and Others
9.6.1. Research Institutes and Others Market, 2018-2030 (USD Million)
Chapter 10. North America and Europe Sepsis Diagnostics Market: Regional Estimates & Trend Analysis
10.1. Regional Market Share Analysis, 2024 & 2030
10.2. Regional Market Dashboard
10.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
10.4. North America
10.4.1. North America Sepsis Diagnostics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
10.4.2. U.S.
10.4.2.1. Key Country Dynamics
10.4.2.2. Regulatory Framework
10.4.2.3. Competitive Insights
10.4.2.4. U.S. Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.4.3. Canada
10.4.3.1. Key Country Dynamics
10.4.3.2. Regulatory Framework
10.4.3.3. Competitive Insights
10.4.3.4. Canada Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5. Europe
10.5.1. Europe Sepsis Diagnostics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
10.5.2. UK
10.5.2.1. Key Country Dynamics
10.5.2.2. Regulatory Framework
10.5.2.3. Competitive Insights
10.5.2.4. UK Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5.3. Germany
10.5.3.1. Key Country Dynamics
10.5.3.2. Regulatory Framework
10.5.3.3. Competitive Insights
10.5.3.4. Germany Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5.4. France
10.5.4.1. Key Country Dynamics
10.5.4.2. Regulatory Framework
10.5.4.3. Competitive Insights
10.5.4.4. France Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5.5. Italy
10.5.5.1. Key Country Dynamics
10.5.5.2. Regulatory Framework
10.5.5.3. Competitive Insights
10.5.5.4. Italy Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5.6. Spain
10.5.6.1. Key Country Dynamics
10.5.6.2. Regulatory Framework
10.5.6.3. Competitive Insights
10.5.6.4. Spain Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5.7. Russia
10.5.7.1. Key Country Dynamics
10.5.7.2. Regulatory Framework
10.5.7.3. Competitive Insights
10.5.7.4. Russia Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5.8. Norway
10.5.8.1. Key Country Dynamics
10.5.8.2. Regulatory Framework
10.5.8.3. Competitive Insights
10.5.8.4. Norway Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5.9. Denmark
10.5.9.1. Key Country Dynamics
10.5.9.2. Regulatory Framework
10.5.9.3. Competitive Insights
10.5.9.4. Denmark Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
10.5.10. Sweden
10.5.10.1. Key Country Dynamics
10.5.10.2. Regulatory Framework
10.5.10.3. Competitive Insights
10.5.10.4. Sweden Sepsis Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 11. Competitive Landscape
11.1. Participant Overview
11.2. Company Market Position Analysis
11.3. Company Categorization
11.4. Strategy Mapping
11.5. Company Profiles/Listing
11.5.1. BD
11.5.1.1. Overview
11.5.1.2. Financial Performance
11.5.1.3. Product Benchmarking
11.5.1.4. Strategic Initiatives
11.5.2. bioMérieux SA
11.5.2.1. Overview
11.5.2.2. Financial Performance
11.5.2.3. Product Benchmarking
11.5.2.4. Strategic Initiatives
11.5.3. Thermo Fisher Scientific Inc.
11.5.3.1. Overview
11.5.3.2. Financial Performance
11.5.3.3. Product Benchmarking
11.5.3.4. Strategic Initiatives
11.5.4. Beckman Coulter, Inc. (Danaher Corporation)
11.5.4.1. Overview
11.5.4.2. Financial Performance
11.5.4.3. Product Benchmarking
11.5.4.4. Strategic Initiatives
11.5.5. F. Hoffmann-La Roche Ltd
11.5.5.1. Overview
11.5.5.2. Financial Performance
11.5.5.3. Product Benchmarking
11.5.5.4. Strategic Initiatives
11.5.6. Cepheid
11.5.6.1. Overview
11.5.6.2. Financial Performance
11.5.6.3. Product Benchmarking
11.5.6.4. Strategic Initiatives
11.5.7. Luminex Corp.
11.5.7.1. Overview
11.5.7.2. Financial Performance
11.5.7.3. Product Benchmarking
11.5.7.4. Strategic Initiatives
11.5.8. Koninklijke Philips N.V.
11.5.8.1. Overview
11.5.8.2. Financial Performance
11.5.8.3. Product Benchmarking
11.5.8.4. Strategic Initiatives
11.5.9. Bruker
11.5.9.1. Overview
11.5.9.2. Financial Performance
11.5.9.3. Product Benchmarking
11.5.9.4. Strategic Initiatives
11.5.10. Immunexpress Inc.
11.5.10.1. Overview
11.5.10.2. Financial Performance
11.5.10.3. Product Benchmarking
11.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. North America and Europe sepsis diagnostics market, by region, 2018-2030 (USD Million)
Table 4. North America and Europe sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 5. North America and Europe sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 6. North America and Europe sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 7. North America and Europe sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 8. North America and Europe sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 9. North America and Europe sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 10. North America sepsis diagnostics market, by country, 2018-2030 (USD Million)
Table 11. North America sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 12. North America sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 13. North America sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 14. North America sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 15. North America sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 16. North America sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 17. U.S. sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 18. U.S. sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 19. U.S. sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 20. U.S. sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 21. U.S. sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 22. U.S. sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 23. Canada sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 24. Canada sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 25. Canada sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 26. Canada sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 27. Canada sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 28. Canada sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 29. Europe sepsis diagnostics market, by country, 2018-2030 (USD Million)
Table 30. Europe sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 31. Europe sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 32. Europe sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 33. Europe sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 34. Europe sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 35. Europe sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 36. UK sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 37. UK sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 38. UK sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 39. UK sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 40. UK sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 41. UK sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 42. Germany sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 43. Germany sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 44. Germany sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 45. Germany sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 46. Germany sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 47. Germany sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 48. France sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 49. France sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 50. France sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 51. France sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 52. France sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 53. France sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 54. Italy sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 55. Italy sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 56. Italy sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 57. Italy sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 58. Italy sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 59. Italy sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 60. Spain sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 61. Spain sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 62. Spain sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 63. Spain sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 64. Spain sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 65. Spain sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 66. Russia sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 67. Russia sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 68. Russia sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 69. Russia sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 70. Russia sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 71. Russia sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 72. Denmark sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 73. Denmark sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 74. Denmark sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 75. Denmark sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 76. Denmark sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 77. Denmark sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 78. Sweden sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 79. Sweden sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 80. Sweden sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 81. Sweden sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 82. Sweden sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 83. Sweden sepsis diagnostics market, by end use, 2018-2030 (USD Million)
Table 84. Norway sepsis diagnostics market, by product, 2018-2030 (USD Million)
Table 85. Norway sepsis diagnostics market, by technology, 2018-2030 (USD Million)
Table 86. Norway sepsis diagnostics market, by pathogen, 2018-2030 (USD Million)
Table 87. Norway sepsis diagnostics market, by testing, 2018-2030 (USD Million)
Table 88. Norway sepsis diagnostics market, by method, 2018-2030 (USD Million)
Table 89. Norway sepsis diagnostics market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 North America and Europe sepsis diagnostics market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Product and technology outlook (USD Million)
Figure 10 Pathogen and testing outlook (USD Million)
Figure 11 Method and end use outlook (USD Million)
Figure 12 Competitive landscape
Figure 13 North America and Europe sepsis diagnostics market dynamics
Figure 14 North America and Europe sepsis diagnostics market: Porter’s five forces analysis
Figure 15 North America and Europe sepsis diagnostics market: PESTLE analysis
Figure 16 North America and Europe sepsis diagnostics market: Product segment dashboard
Figure 17 North America and Europe sepsis diagnostics market: Product market share analysis, 2024 & 2030
Figure 18 Instruments market, 2018-2030 (USD Million)
Figure 19 Blood culture media market, 2018-2030 (USD Million)
Figure 20 Assay kits and reagents market, 2018-2030 (USD Million)
Figure 21 Software market, 2018-2030 (USD Million)
Figure 22 North America and Europe sepsis diagnostics market: Technology segment dashboard
Figure 23 North America and Europe sepsis diagnostics market: Technology market share analysis, 2024 & 2030
Figure 24 Microbiology market, 2018-2030 (USD Million)
Figure 25 Molecular diagnostics market, 2018-2030 (USD Million)
Figure 26 Polymerase chain reaction (PCR) market, 2018-2030 (USD Million)
Figure 27 DNA microarrays market, 2018-2030 (USD Million)
Figure 28 Syndromic panel testing market, 2018-2030 (USD Million)
Figure 29 Others market, 2018-2030 (USD Million)
Figure 30 Immunoassays market, 2018-2030 (USD Million)
Figure 31 Flow cytometry market, 2018-2030 (USD Million)
Figure 32 Others market, 2018-2030 (USD Million)
Figure 33 North America and Europe sepsis diagnostics market: Pathogen segment dashboard
Figure 34 North America and Europe sepsis diagnostics market: Pathogen market share analysis, 2024 & 2030
Figure 35 Bacterial sepsis market, 2018-2030 (USD Million)
Figure 36 Gram-positive bacteria market, 2018-2030 (USD Million)
Figure 37 Gram-negative bacteria market, 2018-2030 (USD Million)
Figure 38 Fungal sepsis market, 2018-2030 (USD Million)
Figure 39 Viral sepsis market, 2018-2030 (USD Million)
Figure 40 Others market, 2018-2030 (USD Million)
Figure 41 North America and Europe sepsis diagnostics market: Testing segment dashboard
Figure 42 North America and Europe sepsis diagnostics market: Testing market share analysis, 2024 & 2030
Figure 43 Laboratory testing market, 2018-2030 (USD Million)
Figure 44 PoC testing market, 2018-2030 (USD Million)
Figure 45 North America and Europe sepsis diagnostics market: Method segment dashboard
Figure 46 North America and Europe sepsis diagnostics market: Method market share analysis, 2024 & 2030
Figure 47 Automated diagnostics market, 2018-2030 (USD Million)
Figure 48 Conventional diagnostics market, 2018-2030 (USD Million)
Figure 49 North America and Europe sepsis diagnostics market: End use segment dashboard
Figure 50 North America and Europe sepsis diagnostics market: End use market share analysis, 2024 & 2030
Figure 51 Hospitals & clinics market, 2018-2030 (USD Million)
Figure 52 Pathology & reference laboratories market, 2018-2030 (USD Million)
Figure 53 Research institutes and others market, 2018-2030 (USD Million)
Figure 54 North America and Europe sepsis diagnostics market revenue, by region
Figure 55 Regional marketplace: Key takeaways
Figure 56 Regional marketplace: Key takeaways
Figure 57 North America sepsis diagnostics market, 2018-2030 (USD Million)
Figure 58 U.S. country dynamics
Figure 59 U.S. sepsis diagnostics market, 2018-2030 (USD Million)
Figure 60 Canada country dynamics
Figure 61 Canada sepsis diagnostics market, 2018-2030 (USD Million)
Figure 62 Europe sepsis diagnostics market, 2018-2030 (USD Million)
Figure 63 UK country dynamics
Figure 64 UK sepsis diagnostics market, 2018-2030 (USD Million)
Figure 65 Germany country dynamics
Figure 66 Germany sepsis diagnostics market, 2018-2030 (USD Million)
Figure 67 France country dynamics
Figure 68 France sepsis diagnostics market, 2018-2030 (USD Million)
Figure 69 Italy country dynamics
Figure 70 Italy sepsis diagnostics market, 2018-2030 (USD Million)
Figure 71 Spain country dynamics
Figure 72 Spain sepsis diagnostics market, 2018-2030 (USD Million)
Figure 73 Russia country dynamics
Figure 74 Russia sepsis diagnostics market, 2018-2030 (USD Million)
Figure 75 Norway country dynamics
Figure 76 Norway sepsis diagnostics market, 2018-2030 (USD Million)
Figure 77 Sweden country dynamics
Figure 78 Sweden sepsis diagnostics market, 2018-2030 (USD Million)
Figure 79 Denmark country dynamics
Figure 80 Denmark sepsis diagnostics market, 2018-2030 (USD Million)
Figure 81 Company categorization
Figure 82 Company market position analysis
Figure 83 Strategic framework

Companies Mentioned

The major companies profiled in this North America and Europe Sepsis Diagnostics market report include:
  • BD
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Beckman Coulter, Inc. (Danaher Corporation)
  • F. Hoffmann-La Roche Ltd
  • Cepheid
  • Luminex Corp.
  • Koninklijke Philips N.V.
  • Bruker
  • Immunexpress Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 816.1 Million
Forecasted Market Value ( USD ) by 2030 $ 1240 Million
Compound Annual Growth Rate7.3%
Regions CoveredEurope, North America
No. of Companies Mentioned10

Related Topics

Related Reports

Sepsis Diagnostic Market by Testing Type, Technology, Product, Method, Pathogen, End-user - Global Forecast 2025-2030 - Product Image

Sepsis Diagnostic Market by Testing Type, Technology, Product, Method, Pathogen, End-user - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen, By Testing, By Method, By End-usse, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen, By Testing, By Method, By End-usse, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Sepsis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Sepsis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Sepsis Diagnostics Market Size By Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), End User & Region - Forecast to 2029 - Product Image

Sepsis Diagnostics Market Size By Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), End User & Region - Forecast to 2029

  • Report
  • 264 Pages
  • Global
From
Sepsis Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Sepsis Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.